Author:
Hart Brian,Cribben Ivor,Fiecas Mark
Funder
Natural Sciences and Engineering Research Council
Alzheimer's Disease Neuroimaging Initiative
National Institutes of Health
DOD ADNI
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
AbbVie
Alzheimer's Association
Alzheimers Drug Discovery Foundation
Araclon Biotech
BioClinica, Inc
Biogen
Bristol-Myers Squibb Company
CereSpir, Inc
Cogstate
Eisai Inc
Elan Pharmaceuticals, Inc
Eli Lilly and Company
EuroImmun
F. Hoffmann-La Roche Ltd
Genentech, Inc
Fujirebio
GE Healthcare
IXICO Ltd
Janssen Alzheimer Immunotherapy Research & Development, LLC
Johnson & Johnson Pharmaceutical Research & Development LLC
Lumosity
Lundbeck
Merck & Co., Inc
Meso Scale Diagnostics, LLC
NeuroRx Research
Neurotrack Technologies
Novartis Pharmaceuticals Corporation
Pfizer Inc
Piramal Imaging
Servier
Takeda Pharmaceutical Company
Transition Therapeutics
Canadian Institutes of Health Research
Subject
Cognitive Neuroscience,Neurology
Reference38 articles.
1. A note on a heteroscedastic model;Amemiya;J. Econom.,1977
2. Controlling the false discovery rate: a practical and powerful approach to multiple testing;Benjamini;J. Roy. Stat. Soc. B,1995
3. Altered functional connectivity in preclinical dementia;Chase;Nat. Rev. Neurol.,2014
4. Heterogeneous aging effects on functional connectivity in different cortical regions: a resting-state functional mri study using functional data analysis;Chen;PLoS One,2016
5. Exact and asymptotically robust permutation tests;Chung;Ann. Stat.,2013
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献